Apellis Pharmaceuticals shares owned by Regent Investment Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Regent Investment Management
from 13F filings
Historical chart of Regent Investment Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Regent Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Regent Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-12-31 | $1.1M | 21k | 51.72 |
| 2022-09-30 | $1.5M | 21k | 68.28 |
| 2022-06-30 | $964k | 21k | 45.24 |
| 2022-03-31 | $1.1M | 21k | 50.82 |
| 2021-12-31 | $1.0M | 21k | 47.26 |
| 2021-09-30 | $702k | 21k | 32.94 |
| 2021-06-30 | $1.3M | 21k | 63.21 |
| 2021-03-31 | $914k | 21k | 42.89 |
| 2020-12-31 | $1.2M | 21k | 57.21 |
| 2020-09-30 | $643k | 21k | 30.18 |
| 2020-06-30 | $696k | 21k | 32.66 |
| 2020-03-31 | $571k | 21k | 26.80 |
| 2019-12-31 | $652k | 21k | 30.60 |
| 2019-09-30 | $513k | 21k | 24.07 |
| 2019-06-30 | $591k | 23k | 25.36 |
More positions owned by Regent Investment Management
View all positions for Regent Investment Management